%0 Journal Article
%T Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia
%A Alice L. Rodriguez
%A Anna L. Blobaum
%A Atin Lamsal
%A Bruce J. Melancon
%A Carrie K. Jones
%A Colleen M. Niswender
%A Darren W. Engers
%A Kellie D. Nance
%A Mark E. Duggan
%A Meredith J. Noetzel
%A Michael
R. Wood
%A Michael Bubser
%A Michael S. Poslusney
%A Michael W. Wood
%A Miguel A. Hurtado
%A Nicholas J. Brandon
%A P. Jeffrey Conn
%A Rebecca L. Weiner
%A Sichen Chang
%A Thomas M. Bridges
%A Vincent B. Luscombe
%J Archive of "ACS Medicinal Chemistry Letters".
%D 2017
%R 10.1021/acsmedchemlett.6b00461
%K Positive allosteric modulator (PAM)
%K muscarinic acetylcholine receptor 4 (M4)
%K VU0467485
%K schizophrenia
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304297/